In conclusion, our study revealed that treatment with CLP significantly reduced cell migration in the peritonitis model and ameliorated the clinical signs, histopathologic damage, and the production of pro-inflammatory cytokines in the colonic tissue in the colitis model, which is possibly linked with the inhibition of the activation of the NF-κB pathway. The gene discussed is NFKB1; the disease is colitis.